Strategies to Overcome Undesired Physicochemical Changes in Particle Engineering for Inhalation

Guardado en:
Detalles Bibliográficos
Publicado en:Kona vol. 42 (2025), p. 121
Autor principal: Gonzalez, Mariana
Otros Autores: Crowther, Julia, Ordoubadi, Mani, Brunaugh, Ashlee D
Publicado:
Hosokawa Powder Technology Foundation
Materias:
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 3187579669
003 UK-CbPIL
022 |a 0288-4534 
022 |a 2187-5537 
024 7 |a 10.14356/kona.2025008  |2 doi 
035 |a 3187579669 
045 2 |b d20250101  |b d20251231 
084 |a 161430  |2 nlm 
100 1 |a Gonzalez, Mariana  |u Department of Pharmaceutical Sciences, University of Michigan, USA 
245 1 |a Strategies to Overcome Undesired Physicochemical Changes in Particle Engineering for Inhalation 
260 |b Hosokawa Powder Technology Foundation  |c 2025 
513 |a Feature 
520 3 |a Particle engineering broadly refers to the controlled production of drug particles optimized for size, morphology, and structure. It encompasses both destructive (top-down) and constructive (bottom-up) particle formation processes, of which the most used for commercial dry powder inhaler (DPI) products are milling and spray drying. In both cases, undesirable physicochemical changes may occur because of thermal and mechanical stresses and through interactions with solvents, and can be further potentiated through storage and interaction with atmospheric water. The occurrence and extent of these phenomena are dependent upon the process parameters and the starting material, which necessitates a thorough understanding of these factors to create a stable product with the necessary characteristics for lung deposition. This review covers commonly arising issues in particle engineering and mechanisms of prevention. Topics to be discussed relating to physical changes include (1) the unintended generation of crystalline disorder and amorphous regions in particles; (2) polymorphic transformations; (3 unintended crystallization when amorphization is desired; and (3) triboelectric charging. Topics to be discussed relating to chemical changes include (1) thermal and mechanically activated chemical reactions; and (2) crystalline disorder and chemical reactivity. 
653 |a Amorphization 
653 |a Cavitation 
653 |a Respiration 
653 |a Chemical reactions 
653 |a Inhalers 
653 |a Spray drying 
653 |a Crystallization 
653 |a Solvents 
653 |a Aerosols 
653 |a Pharmaceutical industry 
653 |a Homogenization 
653 |a Particle size 
653 |a Engineering 
653 |a Crystal lattices 
653 |a Point defects 
653 |a Energy 
653 |a Deformation 
653 |a Thin films 
653 |a Morphology 
653 |a Process parameters 
653 |a Crack propagation 
653 |a Tribo charging 
653 |a Mechanical engineering 
653 |a Process engineering 
700 1 |a Crowther, Julia  |u Department of Pharmaceutical Sciences, University of Michigan, USA 
700 1 |a Ordoubadi, Mani  |u Department of Mechanical Engineering, University of Alberta, Canada 
700 1 |a Brunaugh, Ashlee D  |u Department of Pharmaceutical Sciences, University of Michigan, USA 
773 0 |t Kona  |g vol. 42 (2025), p. 121 
786 0 |d ProQuest  |t Materials Science Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3187579669/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3187579669/fulltext/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3187579669/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch